HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Platelet and plasma BDNF in lower respiratory tract infections of the adult.

Abstract
Enhanced bronchial responsiveness during and following lower respiratory tract infections is a major clinical problem, but its pathogenesis is poorly understood. Brain-derived neurotrophic factor (BDNF), which can be released by platelets and leukocytes, has been identified as a mediator of bronchial hyperresponsiveness. It is unknown whether the release of BDNF is altered during lower respiratory tract infections of the adult. In this clinical pilot study, 16 patients (35-80 years old) with the diagnosis of an acute bacterial lower respiratory tract infection and elevated serum concentrations of c-reactive protein (>100 microg/ml) and procalcitonin (>0.1 ng/ml) were examined on admission to the hospital and 1 week after antibiotic treatment. Sixteen age- and sex-matched controls were examined in the same time period. BDNF concentrations in serum and platelets, but not in plasma, were markedly reduced in patients on the day of admission (median <25% of the controls). Analysis of the platelet marker serotonin (5-HT) suggested that the decrease of platelet BDNF is part of a non-specific release of platelet-derived mediators in this condition. Clinical improvement was accompanied by a restoration of serum and platelet BDNF concentrations which returned to control levels after 1 week of treatment. Cell culture experiments revealed that bacterial lipopolysaccharide (LPS) enhanced the release of BDNF by peripheral blood mononuclear cells of the patients at both time points. In conclusion, these data suggest that lower respiratory tract infections might be associated with an augmented release of BDNF by platelets and mononuclear cells.
AuthorsMarek Lommatzsch, Anke Niewerth, Jens Klotz, Olaf Schulte-Herbrüggen, Christiana Zingler, Peter Schuff-Werner, J Christian Virchow
JournalRespiratory medicine (Respir Med) Vol. 101 Issue 7 Pg. 1493-9 (Jul 2007) ISSN: 0954-6111 [Print] England
PMID17317133 (Publication Type: Journal Article)
Chemical References
  • Anti-Bacterial Agents
  • Brain-Derived Neurotrophic Factor
  • Serotonin
Topics
  • Acute Disease
  • Adult
  • Aged
  • Aged, 80 and over
  • Anti-Bacterial Agents (therapeutic use)
  • Blood Platelets (metabolism)
  • Brain-Derived Neurotrophic Factor (blood)
  • Cells, Cultured
  • Female
  • Humans
  • Leukocytes, Mononuclear (metabolism)
  • Male
  • Middle Aged
  • Pilot Projects
  • Pneumonia, Bacterial (blood, drug therapy)
  • Respiratory Tract Infections (blood, drug therapy)
  • Serotonin (blood)
  • Serum (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: